Allergan Inc.’s patent infringement suits relating to a generic form of Sanctura XR(R), trospium 60 mg. chloride extended release capsules are pending.
In June 2009, the Company received a paragraph 4…
Allergan Inc.’s patent infringement suit against Exela PharmSci, Inc. and Apotex, Inc. remains pending.
In February 2007, the Company received a paragraph 4 invalidity and noninfringement Hatch-Waxman Act certification from Exela…
Allergan Inc.’s consolidated patent infringement actions against Barr Laboratories, Inc. and Sandoz, Inc. remain pending.
In March 2009, the Company received a paragraph 4 invalidity and non-infringement Hatch-Waxman Act certification from…
Apotex Inc. faces a patent infringement complaint by Allergan Inc. over Combigan(R) patents.
In May 2010, the Company received a paragraph 4 invalidity and non-infringement Hatch-Waxman Act certification from Apotex indicating…
The patent infringement litigation between Ocular Research of Boston, Inc. and Allergan Inc. was settled in May 2010.
In August 2007, Ocular Research of Boston, Inc. filed a complaint entitled “Ocular…
Allergan Inc.’s patent infringement suit against Apotex, Inc., is ongoing in the U.S. District Court of Delaware.
In October 2007, the Company received a paragraph 4 invalidity and noninfringement Hatch-Waxman Act…
U.S. District Court proceedings in Allergan Inc.’s consolidated patent infringement actions against Cayman Chemical Company and Athena Cosmetics, Inc. are stayed.
In November 2007, the Company filed a complaint captioned “Allergan,…
Allergan Inc.’s consolidated patent infringement actions against Hi-Tech Pharmacal Co., Sandoz, Inc. and Alcon Research, Ltd. remain pending.
Allergan Inc.’s consolidated patent infringement actions against Hi-Tech Pharmacal Co., Sandoz, Inc. and…
Allergan Inc. pursues a patent infringement complaint against Sandoz, Inc., in the U.S. District Court for the Eastern District of Texas.
In February 2009, the Company received paragraph 4 invalidity and…
The U.S. District Court for the Central District of California has scheduled an Oct. 12, 2010 trial date for Allergan Inc.’s complaint against eight defendants, alleging the infringement of U.S.…